Abstract

BackgroundAnti-Hu and anti-Ri antibodies are paraneoplastic immunoglobulin (Ig)G autoantibodies which recognize cytoplasmic and nuclear antigens present in all neurons. Although both antibodies produce similar immunohistological labeling, they recognize different neuronal proteins. Both antibodies are associated with syndromes of central nervous system dysfunction. However, the neurological deficits associated with anti-Hu antibody are associated with neuronal death and are usually irreversible, whereas neurological deficits in patients with anti-Ri antibody may diminish following tumor removal or immunosuppression.MethodsTo study the effect of anti-Hu and anti-Ri antibodies on neurons, we incubated rat hippocampal and cerebellar slice cultures with anti-Hu or anti-Ri sera from multiple patients. Cultures were evaluated in real time for neuronal antibody uptake and during prolonged incubation for neuronal death. To test the specificity of anti-Hu antibody cytotoxic effect, anti-Hu serum IgG was incubated with rat brain slice cultures prior to and after adsorption with its target Hu antigen, HuD.ResultsWe demonstrated that: 1) both anti-Hu and anti-Ri antibodies were rapidly taken up by neurons throughout both cerebellum and hippocampus; 2) antibody uptake occurred in living neurons and was not an artifact of antibody diffusion into dead cells; 3) intracellular binding of anti-Hu antibody produced neuronal cell death, whereas uptake of anti-Ri antibody did not affect cell viability during the period of study; and 4) adsorption of anti-Hu antisera against HuD greatly reduced intraneuronal IgG accumulation and abolished cytotoxicity, confirming specificity of antibody-mediated neuronal death.ConclusionsBoth anti-Hu and anti-Ri antibodies were readily taken up by viable neurons in slice cultures, but the two antibodies differed markedly in terms of their effects on neuronal viability. The ability of anti-Hu antibodies to cause neuronal death could account for the irreversible nature of paraneoplastic neurological deficits in patients with this antibody response. Our results raise questions as to whether anti-Ri antibody might initially induce reversible neuronal dysfunction, rather than causing cell death. The ability of IgG antibodies to access and react with intracellular neuronal proteins could have implications for other autoimmune diseases involving the central nervous system.Electronic supplementary materialThe online version of this article (doi:10.1186/s12974-014-0160-0) contains supplementary material, which is available to authorized users.

Highlights

  • Anti-Hu and anti-Ri antibodies are paraneoplastic immunoglobulin (Ig)G autoantibodies which recognize cytoplasmic and nuclear antigens present in all neurons

  • We assessed whether specific binding of anti-Hu antibodies to intracellular Hu antigen was required for antibody-mediated cytotoxicity. We found that both antibodies were taken up by neurons and that binding of anti-Hu antibody to its intracellular target antigens induced neuronal death over time, whereas anti-Ri antibody did not induce cell death during the period of study

  • Investigation of anti-Hu or anti-Ri antibody uptake and accumulation by viable neurons in real time To exclude the possibility that detection of intraneuronal IgG might be due to leakage of intravascular Igs into brain parenchyma and neurons after death [41,42], we studied the interaction of anti-Hu and anti-Ri antibodies with neurons in real time as previously described [34]

Read more

Summary

Introduction

Anti-Hu and anti-Ri antibodies are paraneoplastic immunoglobulin (Ig)G autoantibodies which recognize cytoplasmic and nuclear antigens present in all neurons. Both antibodies produce similar immunohistological labeling, they recognize different neuronal proteins. Both antibodies are associated with syndromes of central nervous system dysfunction. Paraneoplastic neurological syndromes associated with anti-Hu antibodies are accompanied by neuronal destruction and usually show no clinical improvement following immunosuppressive treatment or tumor removal [17,18,19,20,21,22]. Some degree of neuronal destruction has been described in cases of anti-Ri encephalomyelitis, findings have been more variable [3,4,23,24], and clinical improvement has been reported in some patients with anti-Ri antibody following immunosuppressive therapy or successful treatment of the underlying malignancy [5,6,18,23,24,25,26,27,28]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call